Skip to main content
Premium Trial:

Request an Annual Quote

DTC Company Reps Behaving Badly

The US Government Accountability Office recently released its findings from a sting conducted on several companies that sell direct-to-consumer genetic tests, finding that the results of such tests are often "of little or no practical use." But, writes Emily Singer in MIT's Technology Review, the most "shocking" findings come from a series of undercover phone calls made to 15 of these companies by GAO workers.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.